Home / Deferoxamine / Canada
CA ATC V03AC01 · updated 2 Nov 2026
Deferoxamine shortage in Canada
Is there a Deferoxamine shortage in Canada?
Yes. As of 2 Nov 2026, 1 Deferoxamine product is reported short in Canada. The company estimate for the return is 23 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | DEFEROXAMINE MESYLATE FOR INJECTION (2G) anticipated | PFIZER CANADA ULC | 6 Nov 2026 | 23 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.